OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
Mark H. Rozenbaum, Elizabeth Begier, Samantha K. Kurosky, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 6, pp. 1487-1504
Open Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

Enhanced safety surveillance of the adjuvanted respiratory syncytial virus vaccine among Italian older adults
Alexander Domnich, Andrea Orsi, Piero Luigi Lai, et al.
Vaccine X (2025), pp. 100647-100647
Open Access

Estimation of GP visits, hospitalizations and deaths attributable to RSV and influenza and costs associated with hospitalizations in older adults in France, 2010-2020
Charles Nuttens, Vanessa Barbet, Clélia Bignon-Favary, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Unveiling the Spectrum of Respiratory Syncytial Virus Disease in Adults: From Community to Hospital
Koos Korsten, Matthijs R. A. Welkers, Thijs van de Laar, et al.
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 5
Open Access

Spatial and temporal variation in respiratory syncytial virus (RSV) subtype RNA in wastewater and relation to clinical specimens
Winnie Zambrana, ChunHong Huang, D. Solis, et al.
mSphere (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 3

Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States
Evan J. Anderson, Ashley Tippett, Elizabeth Begier, et al.
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 3

Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults
Suzanne N. Landi, Diana C. Garofalo, Maya Reimbaeva, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2446010-e2446010
Open Access | Times Cited: 3

Economic burden of cardiorespiratory hospitalizations associated with respiratory syncytial virus among United States adults in 2017–2019
Deesha Patel, Zachary A. Marcum, Aisara Chansakul, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2

Estimated Incidence of Hospitalizations Attributable to RSV Infection Among Adults in Ontario, Canada, Between 2013 and 2019
Marianna Mitratza, Malak Elsobky, Caihua Liang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 9, pp. 1949-1962
Open Access | Times Cited: 2

Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review
Richard Osei‐Yeboah, Stephen Amankwah, Elizabeth Begier, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 9
Open Access | Times Cited: 2

A Model-Based Estimation of RSV-Attributable Incidence of Hospitalizations and Deaths in Italy Between 2015 and 2019
Estelle Méroc, Caihua Liang, Raffaella Iantomasi, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2319-2332
Open Access | Times Cited: 2

Key Challenges to Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Southeast Asia, the Middle East, and North Africa: An Expert Perspective
Hakan Günen, Ashraf Alzaabi, Abdelaziz Bakhatar, et al.
Advances in Therapy (2024) Vol. 41, Iss. 11, pp. 4312-4334
Open Access | Times Cited: 1

Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study
Fabienne Krauer, Felix Guenther, Marina Treskova, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States
Elizabeth M. La, James E. Graham, David Singer, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1

Spatial and temporal variation in respiratory syncytial virus (RSV) subtype RNA in wastewater, and relation to clinical specimens
Winnie Zambrana, ChunHong Huang, D. Solis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Experimental trials of predicted CD4+ and CD8+ T-cell epitopes of respiratory syncytial virus
Syeda Tahira Qousain Naqvi, Syed Aun Muhammad, Jinlei Guo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Burden of Respiratory syncytial virus (RSV) infection among adults in nursing and care homes: a systematic review
Richard Osei‐Yeboah, Stephen Amankwah, Elizabeth Begier, et al.
Authorea (Authorea) (2024)
Open Access

Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study
Fabienne Krauer, Felix Guenther, Marina Treskova, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Unveiling the spectrum of Respiratory Syncytial Virus disease in Adults: from Community to Hospital
Koos Korsten, Matthijs R. A. Welkers, Thijs van de Laar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Reassessing the landscape of viral respiratory infections after the COVID-19 pandemic
Elena Generali, Stefano Aliberti, Maurizio Cecconi, et al.
Archivos de Bronconeumología (2024)
Closed Access

Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options
Matteo Riccò, Bahaa Abu-Raya, Giancarlo Icardi, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1317-1317
Open Access

Previous Page - Page 2

Scroll to top